USANA Health Sciences Inc (USNA.N)
USNA.N on New York Stock Exchange
100.35USD
20 Apr 2018
100.35USD
20 Apr 2018
Change (% chg)
$0.70 (+0.70%)
$0.70 (+0.70%)
Prev Close
$99.65
$99.65
Open
$99.45
$99.45
Day's High
$100.55
$100.55
Day's Low
$99.25
$99.25
Volume
27,883
27,883
Avg. Vol
32,156
32,156
52-wk High
$100.55
$100.55
52-wk Low
$52.55
$52.55
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 273.11 | 1.011 |
| Sep '17 | 261.77 | 0.967 | |
| Jul '17 | 257.06 | 0.930 | |
| Apr '17 | 255.32 | 0.855 | |
| FY 2016 | Dec '16 | 252.90 | 0.874 |
| Oct '16 | 254.22 | 1.202 | |
| Jul '16 | 258.51 | 1.034 | |
| Apr '16 | 240.45 | 0.886 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 3 | 279.81 | 285.86 | 275.56 | 300.80 |
| Quarter Ending Sep-18 | 3 | 282.28 | 289.71 | 277.00 | 292.60 |
| Year Ending Dec-18 | 3 | 1,133.22 | 1,163.86 | 1,114.00 | 1,159.35 |
| Year Ending Dec-19 | 3 | 1,206.88 | 1,247.97 | 1,170.80 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 3 | 1.11 | 1.17 | 1.05 | 1.25 |
| Quarter Ending Sep-18 | 3 | 1.07 | 1.10 | 1.01 | 1.18 |
| Year Ending Dec-18 | 3 | 4.40 | 4.50 | 4.24 | 4.78 |
| Year Ending Dec-19 | 3 | 5.01 | 5.15 | 4.84 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 15.28 | 66.44 | 40.93 | |
| P/E High - Last 5 Yrs. | 18.27 | 35.89 | 41.40 | |
| P/E Low - Last 5 Yrs. | 7.10 | 20.91 | 25.87 | |
| Beta | 1.04 | 0.74 | 0.70 | |
| Price to Sales (TTM) | 1.41 | 7.33 | 5.98 | |
| Price to Book (MRQ) | 3.79 | 4.91 | 37.58 | |
| Price to Tangible Book (MRQ) | 4.35 | 5.80 | 41.47 | |
| Price to Cash Flow (TTM) | 12.99 | 54.97 | 36.00 | |
| % Owned Institutions | 46.18 | 1.08 | 0.16 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.09 | 2.23 | |
| Dividend Yield - 5 Year Avg | -- | 1.05 | 2.51 | |
| Dividend 5 Year Growth Rate | -- | 14.30 | 9.46 | |
| Payout Ratio(TTM) | 0.00 | 41.89 | 59.19 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -0.56 | 2.60 | -1.07 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 5.67 | 5.47 | 5.15 | |
| Sales - 5 Yr. Growth Rate | 11.57 | 8.59 | 10.87 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -10.08 | 24.09 | 1.95 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 1.66 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 38.94 | 11.02 | 8.08 | |
| Capital Spending - 5 Yr. Growth Rate | 25.17 | 15.70 | 7.37 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.93 | 0.92 | 0.87 |
| Current Ratio (MRQ) | 2.44 | 1.21 | 1.50 |
| LT Debt to Equity (MRQ) | 0.00 | 21.38 | 7.52 |
| Total Debt to Equity (MRQ) | 0.00 | 28.73 | 18.43 |
| Interest Coverage (TTM) | -- | 131.49 | 39.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 82.55 | 55.34 | 38.57 | |
| Gross Margin - 5 Yr. Avg. | 82.27 | 45.28 | 37.46 | |
| EBITD Margin (TTM) | 14.45 | -- | -- | |
| EBITD - 5 Yr. Avg | 16.20 | 13.63 | 19.80 | |
| Operating Margin (TTM) | 13.04 | 13.89 | 18.25 | |
| Operating Margin - 5 Yr. Avg. | 14.98 | 11.67 | 18.03 | |
| Pre-Tax Margin (TTM) | 13.15 | 14.06 | 18.34 | |
| Pre-Tax Margin - 5 Yr. Avg. | 14.99 | 12.32 | 17.65 | |
| Net Profit Margin (TTM) | 9.47 | 10.51 | 13.69 | |
| Net Profit Margin - 5 Yr. Avg. | 10.21 | 8.93 | 13.08 | |
| Effective Tax Rate (TTM) | 27.95 | 25.37 | 25.67 | |
| Effective Tax Rate - 5 Yr. Avg. | 31.87 | 22.08 | 25.79 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 570,194 | 14,754,675 | 4,182,652,742 | |
| Net Income/Employee (TTM) | 54,025 | 1,446,874 | 604,628,239 | |
| Receivable Turnover (TTM) | -- | 8.19 | 18.23 | |
| Inventory Turnover (TTM) | 2.54 | 2.64 | 6.14 | |
| Asset Turnover (TTM) | 2.18 | 0.75 | 1.77 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 20.67 | 6.85 | 25.17 | |
| Return on Assets - 5 Yr. Avg. | 23.59 | 14.41 | 29.10 | |
| Return on Investment (TTM) | 28.79 | 10.04 | 62.12 | |
| Return on Investment - 5 Yr. Avg. | 33.05 | 26.88 | 64.34 | |
| Return on Equity (TTM) | 29.40 | 14.35 | 73.69 | |
| Return on Equity - 5 Yr. Avg. | 34.54 | 33.75 | 73.18 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 9.54 | 11.89 | 11.57 |
| EPS (TTM) % | 11.19 | 12.82 | 38.94 |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for USANA Health Sciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.90 | -1.61 | 99 | 7 |
| 13 Week | -7.01 | -11.54 | 47 | 18 |
| 26 Week | 4.33 | -3.60 | 99 | 61 |
| 52 Week | -17.98 | -30.48 | 42 | 26 |
| YTD | -3.59 | -15.34 | 52 | 48 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 50.22% |
| # of Holders: | 233 |
| Total Shares Held: | 12,086,869 |
| 3 Mo. Net Change: | 313,637 |
| # New Positions: | 4 |
| # Closed Positions: | 3 |
| # Increased Positions: | 12 |
| # Reduced Positions: | 13 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.